IDENTIFICATION OF SAFETY ALERT BY MONITORING ANALYTICAL PARAMETERS AND HIGH-RISK DRUGS

Date
2012
Author
Vilaplana, Vicente Escudero-; Pharmacy Department, Gregorio Marañón University General Hospital Doctor Esquerdo 46, 28007 Madrid, Spain
Antúnez, María Gómez-; Internal Medicine Department, Gregorio Marañón University General Hospital, Madrid, Spain
García, Esther Durán-; Pharmacy Department, Gregorio Marañón University General Hospital Doctor Esquerdo 46, 28007 Madrid, Spain
Míguez, Antonio Muiño-; Internal Medicine Department, Gregorio Marañón University General Hospital, Madrid, Spain
Sáez, María Sanjurjo-; Pharmacy Department, Gregorio Marañón University General Hospital Doctor Esquerdo 46, 28007 Madrid, Spain
Metadata
Show full item record
Abstract
Early detection of  adverse  drug  reactions  (ADR) increases patient  safety.  Our  objective  was  to  identify  ADR  by  monitoring laboratory  parameters  and  high-risk  drugs.  We  carried  out  a two-month  prospective  observational  study  in  a  Internal Medicine  Department,  with  daily  recording  of  drugs  prescribed and  the  following  parameters:  Na,  K,  Ca,  serum  creatinine, glomerular  filtration  rate  (GFR),  INR,  glucose,  haemoglobin, platelets,  ALT,  AST,  bilirubin,  GGT,  alkaline  phosphatase,  TSH, T4,  and  blood  digoxin.  High-risk  drugs  were  closely  monitored. 52  patients  included,  of  whom  46.2%  experienced  an  ADR.  We observed  an  association  with  drugs  in  25.5%,  as  follows: reduction  in  GFR,  26.9%  (associated  with  loop  diuretics [41.7%],  angiotensin-converting  enzyme  [ACE]  inhibitors [33.3%],  angiotensin  II  receptor  blockers  [ARB]  [16.6%],  andanti-diabetic  drugs  [8.3%]);  hypokalemia,  22.3%  (associated with  loop  diuretics  [50.0%],  potassium-free  fluid  [37.5%],  and salbutamol  [12.5%]);  hyperkalemia,  14.4%  (associated  with ACE  inhibitors  [60.0%]  and  ARB  [40.0%]);  INR  out  of  range, 10.8%  (associated  with  drug  interactions  [66.7%]); hyperglycemia,  8.1%  (associated  with  corticosteroids  [66.7%] and  anti-diabetic  drugs  [33.3%]);  and  other  conditions,  18.8%. We  conclued  that  patient  safety  could  be  improved  by implementing  warnings  in  electronic  prescriptions  in  cases  of  a decrease  in  GFR  or  modification  of  potassium  levels  in  patients who are prescribed loop diuretics, ACE inhibitors, or ARBs.Key words:   Adverse drug reaction,  clinical decision support,  high-risk drug, safety 
URI
http://indonesianjpharm.farmasi.ugm.ac.id/index.php/3/article/view/674/540 http://indonesianjpharm.farmasi.ugm.ac.id/index.php/3/article/view/674
Collections